<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=118459&amp;fmt=gif">
Show all

Executive Orders Signed to Reduce Drug Prices

executive order

1.5 minute read

President Trump recently signed four executive orders aimed at lowering drug prices. This topic has been a long-standing campaign promise of his administration. The executive orders focus on insulin prices, drug importation, drug rebates, and international pricing. Here’s an overview of the four orders:

  • Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen
    Federally qualified health centers should pass along discounts on insulin and epinephrine received from drug companies to certain low-income Americans.
  • Executive Order on Increasing Drug Importation to Lower Prices for American Patients
    Allow state plans for safe importation of certain drugs, reauthorize the re-importation of U.S. made insulin products, and start widespread use of personal importation waivers at authorized U.S. pharmacies.
  • Executive Order on Access to Affordable Life-saving Medications
    Prohibits secret deals between pharmacy benefit manager middlemen and drug manufacturers. This would help ensure that patients directly benefit from pharmacy discounts.

The fourth order ensures that the United States will pay the lowest price available in economically comparable counties for all Medicare Part B drugs. The U.S. often pays 80% more for these drugs then other developed counties. Implementation of this order has been delayed until August 25, 2020.

The pharmacy industry has condemned the executive orders and will have the opportunity to respond directly to the president. They will discuss proposal alternatives to reduce costs and specifically the international pricing in the fourth executive order.

Download the bulletin for more details.

New call-to-action

National Insurance Services is not a law firm and no opinion, suggestion, or recommendation of the firm or its employees shall constitute legal advice. Readers are advised to consult with their own attorney for a determination of their legal rights, responsibilities and liabilities, including the interpretation of any statute or regulation, or its application to the readers’ business activities.

Market Outlook for 2020/2021
August 05, 2020
notebook with open enrollment written on it with office supplies on desk
2021 Open Enrollment Checklist
August 05, 2020
Nancy Bushard

Nancy Bushard

Nancy Bushard is a firm believer that hard work pays off. True success to her is about providing efficient service and valuable solutions while continually building, refining, and doing the work. Her organized, motivated, and friendly demeanor makes her a great advocate for her customers. As Account Manager for National Insurance Services, Nancy works with schools, cities, and counties in the Midwest Region on their health insurance, wellness plans, benefit communication, and retirement incentives. She oversees new client implementation and meets directly with clients to explain their benefits. Nancy has a strong background in customer service and risk analysis and has been working with employee benefits since 2004. She is a licensed Health and Life insurance agent and is ACA certified.